Acute Kidney Injury Incidence, Risk Factors and Effects on Mortality in Critically ill COVID-19 Patients: A Retrospective Cohort Study
IF 0.1
Q4 CRITICAL CARE MEDICINE
L. Ferliçolak, Irem Alkan Tekes, N. D. Altıntaş
{"title":"Acute Kidney Injury Incidence, Risk Factors and Effects on Mortality in Critically ill COVID-19 Patients: A Retrospective Cohort Study","authors":"L. Ferliçolak, Irem Alkan Tekes, N. D. Altıntaş","doi":"10.37678/dcybd.2022.3251","DOIUrl":null,"url":null,"abstract":"Objective: Acute kidney injury (AKI) is a common condition in critically ill patients, especially those with severe infections, and associated with increased morbidity and mortality. While the main features associated with COVID-19 are extensive alveolar damage and acute respiratory failure, another common complication in patients infected with SARS-CoV-2 is AKI. There is increasing evidence that it affects the kidneys in particular. It was aimed to investigate the frequency and risk factors of AKI development in critically ill COVID-19 patients. Material(s) and Method(s): Between March 15th, 2020 and June 1st, 2021, patients with COVID-19 who were admitted to the intensive care unit(ICU) for more than 24 hours were included in the study and analysed, retrospectively. Patients were grouped according to whether they developed AKI according to KDIGO criteria during the first week of their ICU stay and compared for risk factors. Result(s): There were 206 patients who met the inclusion criteria, of whom 120 had developed AKI during the first week of admission. Patients in AKI group were older with a median age of 70.5 years (p<0.001). The median APACHEII and SOFA scores were higher in the AKI group (20 and 5, respectively, p<0.001). Hypertension was the most common comorbidity and was more frequent in AKI patients (69%, p<0.001), invasive mechanical ventilation (IMV) and vasopressor requirements were more common in AKI patients (78%, p<0.001 and 66%, p<0.001, respectively). In 31 (26%) patients with AKI, renal replacement therapy was required. Mortality rate was higher in AKI patients (68%, p<0.001). Logistic regression analyses revealed hypertension (OR=2.71, %95CI=1.23-5.95, p=0.013) and IMV (OR= 8.15, %95 CI= 3.35-19.83, p< 0.001) as risk factors for AKI. Conclusion(s): AKI is a poor prognostic condition commonly seen in critically ill COVID-19 patients. The rate of AKI development is higher in patients with hypertension and those who need invasive mechanical ventilation. The development of AKI has been associated with high mortality in critically ill COVID-19 patients. Copyright © 2022 by Society of Turkish Intensivist-Available online at www.dcyogunbakim.org.","PeriodicalId":40137,"journal":{"name":"Journal of Critical & Intensive Care","volume":"1 1","pages":""},"PeriodicalIF":0.1000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Critical & Intensive Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37678/dcybd.2022.3251","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Acute kidney injury (AKI) is a common condition in critically ill patients, especially those with severe infections, and associated with increased morbidity and mortality. While the main features associated with COVID-19 are extensive alveolar damage and acute respiratory failure, another common complication in patients infected with SARS-CoV-2 is AKI. There is increasing evidence that it affects the kidneys in particular. It was aimed to investigate the frequency and risk factors of AKI development in critically ill COVID-19 patients. Material(s) and Method(s): Between March 15th, 2020 and June 1st, 2021, patients with COVID-19 who were admitted to the intensive care unit(ICU) for more than 24 hours were included in the study and analysed, retrospectively. Patients were grouped according to whether they developed AKI according to KDIGO criteria during the first week of their ICU stay and compared for risk factors. Result(s): There were 206 patients who met the inclusion criteria, of whom 120 had developed AKI during the first week of admission. Patients in AKI group were older with a median age of 70.5 years (p<0.001). The median APACHEII and SOFA scores were higher in the AKI group (20 and 5, respectively, p<0.001). Hypertension was the most common comorbidity and was more frequent in AKI patients (69%, p<0.001), invasive mechanical ventilation (IMV) and vasopressor requirements were more common in AKI patients (78%, p<0.001 and 66%, p<0.001, respectively). In 31 (26%) patients with AKI, renal replacement therapy was required. Mortality rate was higher in AKI patients (68%, p<0.001). Logistic regression analyses revealed hypertension (OR=2.71, %95CI=1.23-5.95, p=0.013) and IMV (OR= 8.15, %95 CI= 3.35-19.83, p< 0.001) as risk factors for AKI. Conclusion(s): AKI is a poor prognostic condition commonly seen in critically ill COVID-19 patients. The rate of AKI development is higher in patients with hypertension and those who need invasive mechanical ventilation. The development of AKI has been associated with high mortality in critically ill COVID-19 patients. Copyright © 2022 by Society of Turkish Intensivist-Available online at www.dcyogunbakim.org.
COVID-19危重症患者急性肾损伤发生率、危险因素及其对死亡率的影响:一项回顾性队列研究
目的:急性肾损伤(AKI)是危重患者的常见病,尤其是重症感染患者,其发病率和死亡率均较高。虽然与COVID-19相关的主要特征是广泛的肺泡损伤和急性呼吸衰竭,但感染SARS-CoV-2的患者的另一个常见并发症是AKI。越来越多的证据表明,它尤其会影响肾脏。目的探讨COVID-19危重症患者AKI发生的频率及危险因素。材料和方法:将2020年3月15日至2021年6月1日期间入住重症监护病房(ICU)超过24小时的COVID-19患者纳入研究并进行回顾性分析。根据患者在ICU住院的第一周是否根据KDIGO标准发生AKI进行分组,并比较危险因素。结果:206例患者符合纳入标准,其中120例在入院第一周发生AKI。AKI组患者年龄较大,中位年龄为70.5岁(p<0.001)。AKI组中位APACHEII和SOFA评分较高(分别为20分和5分,p<0.001)。高血压是最常见的合并症,在AKI患者中更为常见(69%,p<0.001),有创机械通气(IMV)和血管加压药需求在AKI患者中更为常见(分别为78%,p<0.001和66%,p<0.001)。在31例(26%)AKI患者中,需要肾脏替代治疗。AKI患者的死亡率更高(68%,p<0.001)。Logistic回归分析显示高血压(OR=2.71, %95CI=1.23-5.95, p=0.013)和IMV (OR= 8.15, %95CI= 3.35-19.83, p< 0.001)是AKI的危险因素。结论:AKI是COVID-19危重症患者常见的不良预后状况。高血压患者和需要有创机械通气的患者AKI的发生率较高。AKI的发展与COVID-19危重患者的高死亡率有关。版权所有©2022由土耳其集约化协会-可在www.dcyogunbakim.org在线获取。
本文章由计算机程序翻译,如有差异,请以英文原文为准。